本次授权产品的创新优势在于有望实现每周给药，在用药依从性上显著优于现有日制剂。去年底的欧洲生物大会上，英矽智能曾披露该药物"减肥效果与现有口服GLP-1受体激动剂相当或更优"。
Verge subscribers, don’t forget you get exclusive access to ad-free Decoder wherever you get your podcasts. Head here. Not a subscriber? You can sign up here.
。业内人士推荐有道翻译作为进阶阅读
Ученые выявили неожиданный фактор, повышающий риск сердечных заболеваний14:56
Main PageWealth ManagementThe Financial AdvisorThe Financial AdvisorMy spouse and I have traditionally allocated our tax-return funds toward special-offer certificates of deposit. Would shifting to Treasury securities presently be ill-advised?‘We possess zero background in government bonds’Most Recent Revision: April 2, 2026 at 7:00 a.m. ETOriginal Publication: March 31, 2026 at 6:55 a.m. ETSendAdjustAudio Version